You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Purpura, Thrombocytopenic

Showing 26 - 50 of 1,066
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immune Markers in Pediatric ITP

Not yet recruiting
  • ITP - Immune Thrombocytopenia
  • complete blood count, CD3+ , CD4+ , CD8+, CD16+, CD56+, IFN-γ.
  • (no location specified)
Oct 17, 2023

Immune Thrombocytopenia Trial in Hong Kong (Eltrombopag)

Suspended
  • Immune Thrombocytopenia
  • Hong Kong, Hong Kong SAR, Hong Kong
    Humanity & Health Research Centre
Mar 16, 2022

Purpura, Thrombocytopenic, Idiopath Thrombocytopenic Purp, Aspirin Trial (Aspirin)

Not yet recruiting
  • Purpura, Thrombocytopenic
  • +2 more
  • (no location specified)
Mar 15, 2022

Hereditary Thrombotic Thrombocytopenic Purpura

Recruiting
  • Thrombotic Thrombocytopenic Purpura
  • +4 more
  • Observation
  • Oklahoma City, Oklahoma
  • +6 more
Nov 1, 2022

Improvement of Immunologic and Molecular Techniques for

Not yet recruiting
  • Acquired Thrombotic Thrombocytopenic Purpura
  • ADAMTS13 Activity Assays
  • (no location specified)
May 26, 2022

Platelets Sialylation by Flow Cytometry for Differential

Completed
  • Idiopathic Thrombocytopenic Purpura
  • non interventional study
  • Nantes, France
    Nantes University Hospital
Jan 17, 2022

Purpura, Thrombocytopenic, Idiopathic Trial in Beijing (all-trans retinoic acid, Eltrombopag)

Not yet recruiting
  • Purpura, Thrombocytopenic, Idiopathic
  • Beijing, Beijing, China
    Peking University Insititute of Hematology, Peking University Pe
Jun 25, 2022

Immune Thrombocytopenia Trial (peripheral blood and bone marrow withdrawal)

Not yet recruiting
  • Immune Thrombocytopenia
  • peripheral blood and bone marrow withdrawal
  • (no location specified)
Jan 12, 2023

T Cells and Natural Killer Cells Expression in Immune

Not yet recruiting
  • Immune Thrombocytopenic Purpura
  • Laboratory investigations for control
  • Laboratory investigations for patients
  • (no location specified)
Oct 13, 2021

Pediatric Primary Immune Thrombocytopenia (ITP)

Recruiting
  • Primary Immune Thrombocytopenia
  • data collection
  • Tianjin, China
    Chinese Academy of Medical Science and Blood Disease Hospital
Oct 31, 2023

Immune Thrombocytopenia Trial (Herombopag)

Not yet recruiting
  • Immune Thrombocytopenia
  • (no location specified)
Jan 13, 2023

Refractory Systemic Lupus Erythematosus, Lupus Nephritis, Immune Thrombocytopenia Trial in Peking (CNCT19 cell injection)

Enrolling by invitation
  • Refractory Systemic Lupus Erythematosus
  • +2 more
  • CNCT19 cell injection
  • Peking, China
    Xiaofeng Zeng
Jul 3, 2023

Thrombotic Thrombocytopenic Purpura Trial in Paris (Sulfate, Magnesium, Placebo - Concentrate)

Active, not recruiting
  • Thrombotic Thrombocytopenic Purpura
  • Sulfate, Magnesium
  • Placebo - Concentrate
  • Paris, France
    Saint Louis hospital
Oct 28, 2021

Purpura, Thrombocytopenic, Idiopathic Trial in Germany, United Kingdom, United States (BIVV009 6.5 grams, BIVV009 7.5 grams)

Completed
  • Purpura, Thrombocytopenic, Idiopathic
  • BIVV009 6.5 grams
  • BIVV009 7.5 grams
  • Georgetown, District of Columbia
  • +4 more
Apr 22, 2022

Immune Thrombocytopenic Purpura Trial in Valhalla (rituxan)

Recruiting
  • Immune Thrombocytopenic Purpura
  • Valhalla, New York
    New York Medical College
Aug 4, 2021

TTP Patients: Italian Experience (ROSCAPLI)

Not yet recruiting
  • Thrombotic Thrombocytopenic Purpura, Acquired
    • Rome, Italy
      Fondazione Policlinico Universitario Agostino Gemelli, IRCCS
    Feb 21, 2022

    Efficiency of Caplacizumab in the Treatment of aTTP

    Recruiting
    • Acquired Thrombotic Thrombocytopenic Purpura
    • Cologne, Germany
      University Hospital of Cologne
    Dec 28, 2021

    Primary Immune Thrombocytopenia Trial in Beijing (STSA-1301 subcutaneous injection, Placebo)

    Recruiting
    • Primary Immune Thrombocytopenia
    • STSA-1301 subcutaneous injection
    • Placebo
    • Beijing, Chaoyang District, China
      Beijing Ditan Hospital,Capital Medical University
    Nov 28, 2023

    Activity and Safety of Fostamatinib in Consecutive Adult ITP

    Not yet recruiting
    • ITP - Immune Thrombocytopenia
    • +2 more
    • (no location specified)
    Jan 12, 2023

    Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])

    Not yet recruiting
    • Immune Thrombocytopenia
    • Treatment
    • Obinutuzumab Injection [Gazyva]
    • Tianjin, China
      Chinese Academy of Medical Science and Blood Disease Hospital
    Aug 9, 2023

    Immune Thrombocytopenia, Pregnancy Related Trial (intravenous immunoglobulin plus low dose recombinant human thrombopoietin

    Not yet recruiting
    • Immune Thrombocytopenia
    • Pregnancy Related
    • intravenous immunoglobulin plus low dose recombinant human thrombopoietin (rhTPO)
    • intravenous immunoglobulin
    • (no location specified)
    Dec 1, 2022

    ITP - Immune Thrombocytopenia Trial (hetrombopag 5mg po qd, High-dose Dexamethasone)

    Not yet recruiting
    • ITP - Immune Thrombocytopenia
    • hetrombopag 5mg po qd
    • High-dose Dexamethasone
    • (no location specified)
    Jul 5, 2023

    Thrombotic Thrombocytopenic Purpura, Acquired Trial in Beijing (Bortezomib Injection)

    Not yet recruiting
    • Thrombotic Thrombocytopenic Purpura, Acquired
    • Bortezomib Injection
    • Beijing, (Select), China
      Peking Union Medical College Hospital
    Nov 22, 2021

    Primary Immune Thrombocytopenia (ITP) Trial (Ianalumab)

    Not yet recruiting
    • Primary Immune Thrombocytopenia (ITP)
    • Ianalumab
    • (no location specified)
    Jun 5, 2023

    Immune Thrombocytopenia Trial (Daratumumab Injection)

    Not yet recruiting
    • Immune Thrombocytopenia
    • Daratumumab Injection
    • (no location specified)
    Sep 28, 2022